Jacques Glowinski

Jacques Glowinski's AcademicInfluence.com Rankings

Jacques Glowinski

Biology

#1596

World Rank

#2631

Historical Rank

Neuroscience

#115

World Rank

#122

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Jacques Glowinski Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jacques Glowinski's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I (1966) (5286)
Selective activation of the mesocortical DA system by stress (1976) (1030)
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT (1983) (758)
Dendritic release of dopamine in the substantia nigra (1981) (749)
Astrocytes protect neurons from hydrogen peroxide toxicity (1996) (554)
Hippocampo‐prefrontal cortex pathway: Anatomical and electrophysiological characteristics (2000) (500)
Inhibition of Uptake of Tritiated-noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related Compounds (1964) (482)
Dopaminergic Terminals in the Rat Cortex (1973) (471)
Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover. (1968) (401)
REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN–II (1966) (369)
Gap junctions in cultured astrocytes: Single-channel currents and characterization of channel-forming protein (1991) (365)
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes (1995) (355)
Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. (1973) (351)
Pyruvate Protects Neurons against Hydrogen Peroxide-Induced Toxicity (1997) (346)
Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. (1978) (335)
Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurons of the rat (1979) (331)
Glutamatergic Control of Dopamine Release in the Rat Striatum: Evidence for Presynaptic N‐Methyl‐D‐Aspartate Receptors on Dopaminergic Nerve Terminals (1991) (330)
Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurones (1984) (327)
Release of dopamine in vivo from cat substantia nigra (1977) (325)
EFFECT OF DRUGS ON THE UPTAKE, RELEASE, AND METABOLISM OF H3-NOREPINEPHRINE IN THE RAT BRAIN. (1965) (322)
Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994. (1999) (321)
Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat (1989) (311)
In vivo presynaptic control of dopamine release in the cat caudate nucleus—II. Facilitatory or inhibitory influence ofl-glutamate (1986) (306)
Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. (1966) (305)
Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation (1980) (301)
Relationships between the Prefrontal Cortex and the Basal Ganglia in the Rat: Physiology of the Corticosubthalamic Circuits (1998) (283)
α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates (2002) (280)
Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions (1980) (278)
Mechanism Involved in Initiation and Propagation of Receptor-Induced Intercellular Calcium Signaling in Cultured Rat Astrocytes (1997) (271)
In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. (1979) (266)
Importance of the Noradrenaline–Dopamine Coupling in the Locomotor Activating Effects of d-Amphetamine (1998) (260)
Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effect of nicotine in a low concentration. (1979) (260)
Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the frontocortical dopaminergic innervation in the rat (1978) (258)
G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase (1993) (257)
METABOLISM OF [3H]NOREPINEPHRINE IN THE RAT BRAIN (1965) (254)
Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat. (1977) (237)
Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: Evidence for the involvement of both dopaminergic and GABAergic components (1992) (237)
Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices (1977) (237)
Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system (1975) (234)
Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex (1984) (232)
Bidirectional Activity-Dependent Plasticity at Corticostriatal Synapses (2005) (231)
Daily variations of serotonin metabolism in the rat brain. (1972) (229)
Inhibition by hemicholinium-3 of (14C)acetylcholine synthesis and (3H)choline high-affinity uptake in rat striatal synaptosomes. (1973) (227)
Some evidence for the existence of dopaminergic neurons in the rat cortex. (1973) (226)
Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. (1969) (226)
Spontaneous and Evoked Activity of Substantia Nigra Pars Reticulata Neurons during High-Frequency Stimulation of the Subthalamic Nucleus (2003) (218)
Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat (1978) (209)
Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain (1988) (208)
MAP2 expression and neuritic outgrowth and branching are coregulated through region-specific neuro-astroglial interactions (1987) (201)
Activity-Dependent Neuronal Control of Gap-Junctional Communication in Astrocytes (2000) (199)
Effects of stress on the metabolism of noradrenaline, dopamine and serotonin (5HT) in the central nervous system of the rat. (II). Modifications of serotonin metabolism. (1968) (199)
The mesocortico-prefrontal dopaminergic neurons (1984) (198)
Influence of the hippocampus on interneurons of the rat prefrontal cortex (2004) (191)
Interdependence of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat. (1977) (187)
Excitatory Amino Acid Pathway from the Hippocampus to the Prefrontal Cortex. Contribution of AMPA Receptors in Hippocampo‐prefrontal Cortex Transmission (1992) (186)
Metabolism of norepinephrine in the central nervous system. (1966) (184)
Anatomical and electrophysiological evidence for a direct projection from ammon's horn to the medial prefrontal cortex in the rat (2004) (182)
Nicotinic effect of acetylcholine on the release of newly synthesized [3H]dopamine in rat striatal slices and cat caudate nucleus (1976) (179)
Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. (1966) (177)
Sphingosine‐1‐phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades (2001) (177)
Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat. (1971) (175)
Glutamate-Dependent Phosphorylation of Elongation Factor-2 and Inhibition of Protein Synthesis in Neurons (1997) (171)
Nigral and striatal dopamine release under sensory stimuli (1977) (171)
Effects of drugs on the disposition of H-3-norepinephrine in the rat brain. (1966) (169)
Storage and synthesis of norepinephrine in the reserpine-treated rat brain. (1966) (168)
l-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-d-aspartate receptors (1992) (167)
DYNAMIC CHARACTERISTICS OF THE ‘FUNCTIONAL COMPARTMENT’ OF DOPAMINE IN DOPAMINERGIC TERMINALS OF THE RAT STRIATUM (1971) (165)
Specific stimulation of in vitro maturation of mesencephalic dopaminergic neurones by striatal membranes (1981) (165)
Regulation of serotonin synthesis. (1974) (164)
Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. I. Microestimation of [3H]dopamine uptake and dopamine content in microdiscs (1976) (164)
Effect of noxious tail pinch on the discharge rate of mesocortical and mesolimbic dopamine neurons: selective activation of the mesocortical system (1989) (163)
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo (1992) (158)
5‐HT2A and α1b‐adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants (2004) (158)
A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. (1967) (157)
Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. (1993) (157)
Extensive Co-localization of neurotensin with dopamine in rat meso-cortico-frontal dopaminergic neurons (1988) (156)
In vivo release of [3H]γ-aminobutyric acid in the rat neostriatum—II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen (1986) (155)
Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity. (1973) (155)
The topographical distribution of serotoninergic terminals in the neostriatum of the rat and the caudate nucleus of the cat (1977) (153)
Effects of intranigral application of dopamine and substance P on the in vivo release of newly synthesized [3H]-dopamine in the ipsilateral caudate nucleus of the cat (1977) (153)
Electrophysiological properties of pyramidal neurons in the rat prefrontal cortex: an in vivo intracellular recording study. (2002) (153)
Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex (1988) (152)
Adrenergic regulation of intercellular communications between cultured striatal astrocytes from the mouse. (1991) (147)
Knock-Out of the Neural Death Effector Domain Protein PEA-15 Demonstrates That Its Expression Protects Astrocytes from TNFα-Induced Apoptosis (1999) (147)
In Vivo Release of Endogenous Amino Acids from the Rat Striatum: Further Evidence for a Role of Glutamate and Aspartate in Corticostriatal Neurotransmission (1986) (145)
AN ADAPTATION OF THE PUSH‐PULL CANNULA METHOD TO STUDY THE IN VIVO RELEASE OF [3H]DOPAMINE SYNTHESIZED FROM [3H]TYROSINE IN THE CAT CAUDATE NUCLEUS: EFFECTS OF VARIOUS PHYSICAL AND PHARMACOLOGICAL TREATMENTS (1977) (144)
Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D‐1 Dopamine Receptor (1991) (140)
Biochemical investigation on the localization of the cholecystokinin octapeptide in dopaminergic neurons originating from the ventral tegmental area of the rat (1981) (139)
Selective activation of the mesocortico-frontal dopaminergic neurons induced by lesion of the habenula in the rat (1980) (139)
Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment. (1970) (137)
Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. (1967) (137)
Functional aspects of serotonin transmission in the basal ganglia: A review and in vivo approach using the push-pull cannula technique (1984) (136)
Topographical distribution of dopaminergic innervation and dopaminergic receptors of the anterior cerebral cortex of the rat (1978) (132)
Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study. (1973) (131)
Tyrosine hydroxylase activation in depolarized dopaminergic terminals—involvement of Ca2+ -dependent phosphorylation (1983) (131)
Blockade of Prefronto‐cortical α1‐Adrenergic Receptors Prevents Locomotor Hyperactivity Induced by Subcortical D‐Amphetamine Injection (1994) (130)
Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action (1994) (130)
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. (1966) (130)
Synaptic influence of hippocampus on pyramidal cells of the rat prefrontal cortex: an in vivo intracellular recording study. (2003) (129)
In vivo presynaptic control of dopamine release in the cat caudate nucleus—III. Further evidence for the implication of corticostriatal glutamatergic neurons (1986) (129)
Glutamate-evoked release of arachidonic acid from mouse brain astrocytes (1994) (129)
Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus (1981) (128)
Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to d-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens (1988) (128)
Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice (1998) (128)
Specific Binding of a 125I‐Substance P Derivative to Rat Brain Synaptosomes (1983) (127)
Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. (1994) (126)
Gabaergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat. (1978) (126)
Possible existence of a new tachykinin receptor subtype in the guinea pig ileum (1992) (125)
Segregation and Convergence of Information Flow through the Cortico-Subthalamic Pathways (2001) (125)
Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat (1978) (124)
Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites (2003) (124)
Anatomical and Electrophysiological Evidence for an Excitatory Amino Acid Pathway from the Thalamic Mediodorsal Nucleus to the Prefrontal Cortex in the Rat (1994) (123)
Relationships between the Prefrontal Cortex and the Basal Ganglia in the Rat: Physiology of the Cortico-Nigral Circuits (1999) (122)
Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock. (1969) (121)
In vivo release of acetylcholinesterase in cat substantia nigra and caudate nucleus (1980) (121)
Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit (1996) (120)
Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum (1991) (119)
Critical role of α1‐adrenergic receptors in acute and sensitized locomotor effects of D‐amphetamine, cocaine, and GBR 12783: Influence of preexposure conditions and pharmacological characteristics (2002) (118)
Opposite changes in dopamine utilization in the nucleus accumbens and the frontal cortex after electrolytic lesion of the median raphe in the rat (1981) (115)
Spatial organization of patch and matrix compartments in the rat striatum (1993) (114)
Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. (2006) (114)
Role of the dendritic release of dopamine in the reciprocal control of the two nigro-striatal dopaminergic pathways (1979) (113)
Increased Turnover of Cerebral Norepinephrine during Rebound of Paradoxical Sleep in the Rat (1968) (112)
Vasoactive Intestinal Polypeptide Receptors Linked to an Adenylate Cyclase, and Their Relationship with Biogenic Amine‐ and Somatostatin‐Sensitive Adenylate Cyclases on Central Neuronal and Glial Cells in Primary Cultures (1985) (112)
Increase in External Glutamate and NMDA Receptor Activation Contribute to H2O2‐Induced Neuronal Apoptosis (1999) (111)
Endothelins regulate astrocyte gap junctions in rat hippocampal slices (2004) (111)
Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain (2005) (110)
Neuroleptic-Induced Catalepsy: Electrophysiological Mechanisms of Functional Recovery Induced by High-Frequency Stimulation of the Subthalamic Nucleus (2005) (110)
Cellular Expression, Developmental Regulation, and Phylogenic Conservation of PEA‐15, the Astrocytic Major Phosphoprotein and Protein Kinase C Substrate (1995) (109)
Stimulation of dopamine release by GABA in rat striatal slices (1978) (109)
Electrical and chemical transmission between striatal GABAergic output neurones in rat brain slices (2004) (107)
PHYSIOLOGICAL DISPOSITION OF H3-NOREPINEPHRINE IN THE DEVELOPING RAT. (1964) (107)
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. (1984) (107)
Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections. (1992) (106)
Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain. (1986) (105)
d-Amphetamine Fails to Increase Extracellular Dopamine Levels in Mice Lacking α1b-Adrenergic Receptors: Relationship between Functional and Nonfunctional Dopamine Release (2002) (105)
The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. (1965) (104)
Long-term development of mesencephalic dopaminergic neurons of mouse embryos in dissociated primary cultures: Morphological and histochemical characteristics (1982) (103)
Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase — Interaction of d-LSD with dopaminergic receptors (1976) (103)
Tachykinin Receptors of the NK1 Type (Substance P) Coupled Positively to Phospholipase C on Cortical Astrocytes from the Newborn Mouse in Primary Culture (1989) (103)
Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization. (1991) (103)
Substance P receptors in primary cultures of cortical astrocytes from the mouse. (1986) (98)
Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain (1986) (98)
Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics (1976) (97)
Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons (1988) (97)
Is the dopaminergic mesocorticolimbic system necessary for intracranial self-stimulation? Biochemical and behavioral studies from A10 cell bodies and terminals. (1979) (96)
Role of hypothalamic monoaminergic neurones in the gonadotrophin release-regulating mechanisms. (1972) (95)
Modulation by Monoamines of Somatostatin‐Sensitive Adenylate Cyclase on Neuronal and Glial Cells from the Mouse Brain in Primary Cultures (1985) (95)
Effects of some psychotropic drugs on dopamine synthesis in the rat striatum. (1971) (95)
Effect of sodium, hemicholinium-3 and antiparkinson drugs on (14C)acetylcholine synthesis and (3H)choline uptake in rat striatal synaptosomes. (1973) (94)
Drugs of Abuse Specifically Sensitize Noradrenergic and Serotonergic Neurons Via a Non-Dopaminergic Mechanism (2008) (93)
Endothelin Induces a Calcium‐Dependent Phosphorylation of PEA‐15 in Intact Astrocytes: Identification of Ser104 and Ser116 Phosphorylated, Respectively, by Protein Kinase C and Calcium/Calmodulin Kinase II In Vitro (1998) (93)
Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra. (1974) (93)
Difference in the reactivity of the mesocortical dopaminergic neurons to stress in the BALB/C and C57 BL/6 mice. (1979) (92)
Specific influence of striatal target neurons on the in vitro outgrowth of mesencephalic dopaminergic neurites: a morphological quantitative study (1983) (92)
Anandamide and WIN 55212‐2 inhibit cyclic AMP formation through G‐protein‐coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes (1999) (92)
Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat (1982) (91)
Brain astrocytes express region‐specific surface glycoproteins in culture (1988) (90)
Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum. (1973) (90)
Gap junctional communication and pharmacological heterogeneity in astrocytes cultured from the rat striatum (1998) (89)
Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus. (1989) (89)
Effects of LSD on synthesis and release of 5-HT in rat brain slices. (1974) (88)
Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat (1975) (88)
Increased synthesis and utilization of serotonin in the central nervous system of the rat during paradoxical sleep deprivation. (1970) (87)
In vivo release of 5-HT in the lateral ventricle of the rat: effects of 5-hydroxytryptophan and tryptophan (1976) (86)
FEEDBACK REGULATION OF 5‐HT SYNTHESIS IN RAT STRIATAL SLICES (1973) (85)
Pyruvate and lactate protect striatal neurons against N‐methyl‐d‐aspartate‐induced neurotoxicity (1999) (85)
Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles (1979) (85)
A neuroglial cooperativity is required for the potentiation by 2- chloroadenosine of the muscarinic-sensitive phospholipase C in the striatum (1989) (84)
Non-DA prefronto-cortical efferents modulate D1 receptors in the nucleus accumbens (1984) (84)
ISOLATION AND RADIOENZYMIC ESTIMATION OF PICOGRAM QUANTITIES OF DOPAMINE AND NOREPINEPHRINE IN BIOLOGICAL SAMPLES (1976) (84)
Modulation of dopamine release in rat striatal slices by delta opiate agonists. (1982) (84)
Effect of nerve activity on the in vivo release of [3H]serotonin continuously formed from l-[3H]tryptophan in the caudate nucleus of the cat (1979) (84)
Interleukin-1 Enhances the ATP-Evoked Release of Arachidonic Acid from Mouse Astrocytes (1997) (83)
Calpain product of WT‐CRMP2 reduces the amount of surface NR2B NMDA receptor subunit (2006) (83)
Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat (1979) (83)
FEEDBACK CONTROL OF RAT BRAIN 5‐HYDROXYTRYPTAMINE SYNTHESIS 1 (1971) (83)
Basal ganglia and processing of cortical information: functional interactions between trans-striatal and trans-subthalamic circuits in the substantia nigra pars reticulata (2003) (83)
Endothelins Inhibit Junctional Permeability in Cultured Mouse Astrocytes (1992) (83)
Characteristics of dopamine and β-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases (1977) (82)
Three-dimensional organization of the striosomal compartment and patchy distribution of striatonigral projections in the matrix of the cat caudate nucleus (1989) (82)
In vivo release of [3H]γ-aminobutyric acid in the rat neostriatum—I. Characterization and topographical heterogeneity of the effects of dopaminergic and cholinergic agents (1986) (82)
Prefrontal cortex‐basal ganglia circuits in the rat: Involvement of ventral pallidum and subthalamic nucleus (1998) (81)
Symmetric bilateral changes in dopamine release from the caudate nuclei of the cat induced by unilateral nigral application of glycine and gaba-related compounds (1979) (81)
ACETYLCHOLINE SYNTHESIS FROM [2‐14C]PYRUVATE IN RAT STRIATAL SLICES (1973) (81)
Position of the ventral pallidum in the rat prefrontal cortex–basal ganglia circuit (1997) (81)
Homotypic and Heterotypic Coupling Mediated by Gap Junctions During Glial Cell Differentiation In Vitro (1995) (81)
Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with ‘autoreceptors’? (1976) (81)
PLASMA TRYPTOPHAN AND 5‐HT METABOLISM IN THE CNS OF THE NEWBORN RAT (1974) (81)
Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex (1986) (81)
Contribution of Noradrenergic Neurons to the Regulation of Dopaminergic (D1) Receptor Denervation Supersensitivity in Rat Prefrontal Cortex (1986) (80)
Involvement of lateral habenula-dorsal raphe neurons in the differential regulation of striatal and nigral serotonergic transmission cats (1982) (79)
[3H]HARMALINE AS A SPECIFIC LIGAND OF MAO A—I. PROPERTIES OF THE ACTIVE SITE OF MAO A FROM RAT AND BOVINE BRAINS (1979) (78)
Stimulating effects of gamma-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat. (1977) (78)
Radioautographic study of in vivo incorporation of3H-monoamines in the cat caudate nucleus: Identification of serotoninergic fibers (1976) (78)
Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors (2003) (78)
Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus. (1970) (78)
Dopamine uptake in serotoninergic terminals in vitro: A valuable tool for the histochemical differentiation of catecholaminergic and serotoninergic terminals in rat cerebral structures (1978) (77)
Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens (1982) (76)
Retrograde axonal transport of125I-tetanus toxin as a too for tracing fiber connections in the central nervous system; connections of the rostral part of the rat neostriatum (1977) (76)
The Major Astrocytic Phosphoprotein PEA-15 Is Encoded by Two mRNAs Conserved on Their Full Length in Mouse and Human* (1996) (76)
Differential Modulation of D1 and D2 Dopamine‐Sensitive Adenylate Cyclases by 17β‐Estradiol in Cultured Striatal Neurons and Anterior Pituitary Cells (1989) (76)
Effects of Arachidonic Acid on Dopamine Synthesis, Spontaneous Release, and Uptake in Striatal Synaptosomes from the Rat (1995) (74)
Inhibition of hippocampo-prefrontal cortex excitatory responses by the mesocortical DA system (1995) (74)
Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways. (1979) (74)
Glutamate Receptors of a Quisqualate‐Kainate Subtype are Involved in the Presynaptic Regulation of Dopamine Release in the Cat Caudate Nucleus in vivo (1990) (74)
Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release. (1986) (73)
[3H]Neurokinin B and 125I‐Bolton Hunter Eledoisin Label Identical Tachykinin Binding Sites in the Rat Brain (1987) (73)
Presynaptic Dopamine Autoreceptors Control Tyrosine Hydroxylase Activation in Depolarized Striatal Dopaminergic Terminals (1986) (73)
Chlordiazepoxide reduces in vivo serotonin release in the basal ganglia of encéphale isolé but not anesthetized cats: evidence for a dorsal raphe site of action. (1983) (72)
Electrical Synapses between Dopaminergic Neurons of the Substantia Nigra Pars Compacta (2005) (71)
Increased release of dopane from striatal dopaminergic terminals in the rat after treatment with a neuroleptic: thioproperazine. (1970) (71)
Chapter 18 Influence of the ascending monoaminergic systems on the activity of the rat prefrontal cortex (1991) (70)
Brain macrophages inhibit gap junctional communication and downregulate connexin 43 expression in cultured astrocytes (2002) (70)
Routes of zinc entry in mouse cortical neurons: role in zinc‐induced neurotoxicity (2000) (70)
In vivo release of met-enkephalin in the cat brain (1981) (69)
Effect of quipazine, a serotonin-like drug, on striatal cholinergic interneurones. (1977) (68)
Inhibition of dopamine release in the cat caudate nucleus by nigral application of glycine. (1978) (67)
Effect of the immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopamine-ergic neurons (1978) (67)
Daily variations of various parameters of serotonin metabolism in the rat brain. I. Circadian variations of tryptophan-5-hydroxylase in the raphe nuclei and the striatum (1977) (67)
Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: Evidence for the existence of storage sites containing the two transmitters (1984) (67)
Autoradiography of CCK receptors in the rat brain using [3H]Boc[Nle28 31]CCK27–33 and [125I]bolton-hunter CCK8. Functional significance of subregional distributions (1987) (66)
Involvement of the thalamus in the reciprocal regulation of the two nigrostriatal dopaminergic pathways (1981) (66)
Activation by stress of the habenulo-interpeduncular substance P neurons in the rat (1981) (66)
Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal corte by mesencephalic raphe nuclei (1990) (66)
Differential effects of a two-minute open-field session on dopamine utilization in the frontal cortices of BALB/c and C57 BL/6 mice (1980) (66)
Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission. (1992) (66)
Glial receptors and their intervention in astrocyto–astrocytic and astrocyto–neuronal interactions (1994) (65)
A 25 year adventure in the field of tachykinins (2004) (65)
Interhemispheric and subcortical collaterals of medial prefrontal cortical neurons in the rat (1987) (65)
3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle. (1987) (65)
THE ROLE OF INTRANEURONAL 5‐HT AND OF TRYPTOPHAN HYDROXYLASE ACTIVATION IN THE CONTROL OF 5‐HT SYNTHESIS IN RAT BRAIN SLICES INCUBATED IN K+‐ENRICHED MEDIUM (1979) (65)
ATP-induced inhibition of gap junctional communication is enhanced by interleukin-1 β treatment in cultured astrocytes (2004) (64)
Properties and Functions of Intraneuronal Monoamine Compartments in Central Aminergic Neurons (1975) (64)
A role for striatal beta-adrenergic receptors in the regulation of dopamine release (1982) (64)
Competitive Inhibition of N‐Acetylated‐α‐Linked Acidic Dipeptidase Activity by N‐Acetyl‐L‐Aspartyl‐β‐Linked L‐Glutamate (1990) (64)
Differential localization of tachykinin receptors in rat spinal cord. (1984) (63)
Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture. (1982) (63)
In vivo presynaptic control of dopamine release in the cat caudate nucleus—I. Opposite changes in neuronal activity and release evoked from thalamic motor nuclei (1986) (63)
Effects of unilateral electrical stimulation of various thalamic nuclei on the release of dopamine from dendrites and nerve terminals of neurons of the two nigrostriatal dopaminergic pathways (1983) (63)
Neuromedin K, a tool to further distinguish two central tachykinin binding sites. (1984) (63)
Glycine potentiates the NMDA-induced release of dopamine through a strychnine-insensitive site in the rat striatum. (1989) (62)
Effects of acute dopamine depletion on the electrophysiological properties of striatal neurons (2007) (61)
An Abundant mRNA of the Embryonic Brain Persists at a High Level in Cerebellum, Hippocampus and Olfactory Bulb During Adulthood (1993) (61)
Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons. (1977) (61)
Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum. (1972) (61)
Characteristics of Tyrosine Hydroxylase Activation by K+‐Induced Depolarization and/or Forskolin in Rat Striatal Slices (1985) (61)
Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat (1990) (60)
Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat. (1979) (60)
Daily variations of various parameters of serotonin metabolism in the rat brain. II. Circadian variations in serum and cerebral tryptophan levels: Lack of correlation with 5-HT turnover (1977) (59)
Somatostatin potentiates the alpha 1-adrenergic activation of phospholipase C in striatal astrocytes through a mechanism involving arachidonic acid and glutamate. (1991) (59)
Activation of the bilateral corticostriatal glutamatergic projection by infusion of GABA into thalamic motor nuclei in the cat: An in vivo release study (1989) (58)
Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation (2005) (57)
Design and synthesis of side-chain conformationally restricted phenylalanines and their use for structure-activity studies on tachykinin NK-1 receptor. (1994) (57)
Release of dopamine from dissociated mesencephalic dopaminergic neurons in primary cultures in absence or presence of striatal target cells (1980) (57)
Effects of amphetamine and desmethylimipramine on amines synthesis and release in central catecholamine-containing neurons. (1969) (57)
Selective inhibition of superovulation by blockade of dopamine synthesis during the "critical period" in the immature rat. (1969) (56)
Effets of adrenalectomy on the turnover of norepinephrine in the rat brain. (1968) (56)
Behavioural deficits induced by an electrolytic lesion of the rat ventral mesencephalic tegmentum are corrected by a superimposed lesion of the dorsal noradrenergic system (1988) (56)
Stathmin Is a Major Phosphoprotein and Cyclic AMP‐Dependent Protein Kinase Substrate in Mouse Brain Neurons but Not in Astrocytes in Culture: Regulation During Ontogenesis (1989) (56)
Topographical organization of efferent projections from the cat substantia nigra pars reticulata (1988) (54)
Local cerebral glucose consumption in the rat. I. Effects of halothane anesthesia (1983) (54)
Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors (1992) (53)
Dendritic Arborizations of the Rat Substantia Nigra Pars Reticulata Neurons: Spatial Organization and Relation to the Lamellar Compartmentation of Striato-Nigral Projections (2001) (53)
[Epidemiological aspects of osteoarticular tuberculosis in adults. Retrospective study of 206 cases diagnosed in the Paris area from 1980 to 1994]. (1997) (53)
In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathway. (1973) (53)
Opposite effects of sulfated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens. (1986) (53)
Role of dynorphin and GABA in the inhibitory regulation of NMDA-induced dopamine release in striosome- and matrix-enriched areas of the rat striatum (1994) (53)
Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin (1980) (52)
[3H]Metergoline: A New Ligand of Serotonin Receptors in the Rat Brain (1981) (52)
Changes in striatal specific 3-H-atropine binding after unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurones. (1978) (52)
Local cerebral glucose consumption in the rat. II. Effects of unilateral substantia nigra stimulation in conscious and in halothane‐anesthetized animals (1983) (52)
Different Subtypes of Tachykinin NK1 Receptor Binding Sites Are Present in the Rat Brain (2000) (52)
Involvement of the thalamus in the asymmetric effects of unilateral sensory stimuli on the two nigrostriatal dopaminergic pathways in the cat (1981) (51)
Role of serotonin2A receptors in the d‐amphetamine‐induced release of dopamine: comparison with previous data on α1b‐adrenergic receptors (2004) (51)
Blockade of superovulation in the immature rat by increased brain serotonin. (1968) (51)
Presence of dopaminergic terminals and absence of dopaminergic cell bodies in the cerebral cortex of the cat. (1974) (51)
Antiproliferative properties of sphingosine-1-phosphate in human hepatic myofibroblasts. (2001) (51)
The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea but not in the rat. (1993) (50)
Spontaneous and potassium-evoked release of 3H-GABA newly synthesized from 3H-glutamine in slices of the rat substantia nigra. (1979) (50)
Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay) (1991) (50)
Cooperative contributions of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum. (1996) (49)
Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the cat (1983) (49)
Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists (1993) (49)
Nondopaminergic prefrontocortical efferent fibers modulate D1 receptor denervation supersensitivity in specific regions of the rat striatum (1989) (49)
Role of dynorphin-containing neurons in the presynaptic inhibitory control of the acetylcholine-evoked release of dopamine in the striosomes and the matrix of the cat caudate nucleus (1991) (48)
Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors (1992) (48)
Selective agonists of tachykinin binding sites (1990) (47)
Characteristics of tryptophan accumulation by glial cells (1974) (47)
Acute changes in central serotonin metabolism induced by the blockade or stimulation of serotoninergic receptors during ontogenesis in the rat. (1977) (47)
High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands. (1997) (46)
5‐HYDROXYTRYPTAMINE CATABOLISM IN THE RAT BRAIN DURING ONTOGENESIS (1977) (45)
Preferential utilization of newly synthesized norepinephrine in the brain stem of stressed rats. (1970) (45)
In vivo release of substance P in the cat substantia nigra (1979) (45)
Dopamine modulates temporal dynamics of feedforward inhibition in rat prefrontal cortex in vivo. (2008) (45)
Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of substance P in substantia nigra slices of the rat. (1981) (45)
The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum (2004) (45)
The 'septide-sensitive' tachykinin receptor: still an enigma. (1995) (44)
Pharmacological characterisation of two tachykinin binding sites in the rat cerebral cortex (1985) (44)
Hydrogen peroxide increases gap junctional communication and induces astrocyte toxicity: Regulation by brain macrophages (2004) (44)
In vivo release of endogenously synthesized [3H]GABA from the cat substantia nigra and the pallido-entopeduncular nuclei (1980) (44)
The in vivo release of acetylcholine from cat caudate nucleus after pharmacological and surgical manipulations of dopaminergic nigrostriatal neurons. (1973) (44)
[Chronic refractory pain in cancer patients. Value of the spinal injection of lysine acetylsalicylate. 60 cases]. (1987) (44)
Biogenic amines and adenosine-sensitive adenylate cyclases in primary cultures of striatal neurons. (1983) (43)
Mu and delta opiate receptors coupled negatively to adenylate cyclase on embryonic neurons from the mouse striatum in primary cultures (1988) (43)
Presynaptic facilitation of dopamine release through D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum. (1991) (43)
Contribution of an α1-adrenergic receptor subtype to the expression of the “ventral tegmental area syndrome” (1992) (43)
Oxotremorine‐ and atropine‐induced changes of dopamine metabolism in the rat striatum (1975) (42)
Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation (1986) (42)
Regional differences in the sensitivity of cholinergic neurons to dopaminergic drugs and quipazine in the rat striatum (1977) (42)
Mediodorsal thalamic evoked responses in the rat prefrontal cortex: influence of the mesocortical DA system. (1996) (42)
Effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the cat. (1982) (41)
Stimulation of metabotropic but not ionotropic glutamatergic receptors in the nucleus accumbens is required for the d-amphetamine-induced release of functional dopamine (2001) (41)
α1‐adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: Implications for the modality of action of different types of neuroleptics (1998) (41)
Distinct commissural pathways are involved in the enhanced release of dopamine induced in the contralateral caudate nucleus and substantia nigra by unilateral application of GABA in the cat thalamic motor nuclei (1984) (41)
[Pro9]SP and [pGLU6, PRO9]SP(6–11) interact with two different receptors in the guinea-pig ileum as demonstrated with new SP antagonists (1992) (41)
Neurons Promote Macrophage Proliferation by Producing Transforming Growth Factor-β2 (1997) (41)
Synergistic Regulation of Cytosolic Ca2+ Concentration in Mouse Astrocytes by NK1 Tachykinin and Adenosine Agonists (1991) (41)
Blockade of D‐1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre‐ and postsynaptic indices of dopamine function in the nucleus accumbens (1994) (41)
Development of cortical and nigro-neostriatal dopaminergic systems after destruction of central noradrenergic neurones in foetal or neonatal rats (1975) (41)
Facilitation by Endogenous Tachykinins of the NMDA-Evoked Release of Acetylcholine after Acute and Chronic Suppression of Dopaminergic Transmission in the Matrix of the Rat Striatum (2002) (40)
Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats (1986) (40)
Muscarinic cholinergic agonists stimulate arachidonic acid release from mouse striatal neurons in primary culture. (1994) (40)
Local GABAergic regulation of the N-methyl-d-aspartate-evoked release of dopamine is more prominent in striosomes than in matrix of the rat striatum (1993) (40)
Inhibition of high-affinity choline transport in rat striatal synaptosomes by alkyl bisquaternary ammonium compounds. (1975) (39)
Some characteristics of the 'functional' and 'main storage' compartments in central catecholaminergic neurons. (1973) (39)
Chemical transmission between dopaminergic neuron pairs (2008) (39)
Evoked Release of Proteins from Central Neurons In Vivo (1983) (39)
Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons. (1971) (38)
Synthesis and biological activities of substance P iodinated derivatives. (1980) (38)
Presence of NK2 binding sites in the rat brain (2001) (38)
Inhibition of protein synthesis in cortical neurons during exposure to hydrogen peroxide (2001) (38)
Zinc Inhibits Protein Synthesis in Neurons (1999) (38)
Studies on mesocortical dopamine systems. (1978) (38)
Stimulatory effect of substance P on the spontaneous release of newly synthesized [3H]dopamine from rat striatal slices: A tetrodotoxin-sensitive process (1986) (38)
Further Demonstration that [Pro9]‐Substance P Is a Potent and Selective Ligand of NK‐1 Tachykinin Receptors (1991) (38)
Bilateral asymmetrical changes in the nigral release of [3H]GABA induced by unilateral application of acetylcholine in the cat caudate nucleus (1982) (37)
An autoradiographic study of the distribution of C14-norepinephrine in the brain of the rat. (1967) (37)
Endothelin‐evoked Release of Arachidonic Acid from Mouse Astrocytes in Primary Culture (1992) (37)
Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801. (1997) (37)
Excitatory responses evoked in prefrontal cortex by mediodorsal thalamic nucleus stimulation: influence of anaesthesia. (1995) (36)
Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes (1994) (36)
Lymph node tuberculosis in the suburbs of Paris: 59 cases in adults not infected by the human immunodeficiency virus. (1999) (36)
Origin of the acetyl moiety of acetylcholine synthesized in rat striatal synaptosomes. (1977) (36)
The physiologic disposition of H3-histamine in the rat brain. (1966) (36)
Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes (1994) (35)
Bilateral cerebral metabolic alterations following lesion of the ventromedial thalamic nucleus: Mapping by the 14C‐deoxyglucose method in conscious rats (1985) (35)
Marked Regional Heterogeniety of 125I‐Bolton Hunter Substance P Binding and Substance P‐Induced Activation of Phospholipase C in Astrocyte Cultures from the Embryonic or Newborn Rat (1990) (35)
Multiple receptors for serotonin in the rat brain. (1980) (35)
Pharmacological and Functional Heterogeneity of Astrocytes: Regional Differences in Phospholipase C Stimulation by Neuromediators (1989) (35)
Discovery of the mesocortical dopaminergic system: some pharmacological and functional characteristics. (1977) (35)
THE STORAGE OF NOREPINEPHRINE AND SOME OF ITS DERIVATIVES IN BRAIN SYNAPTOSOMES. (1965) (34)
Stimulation of postsynaptic α1b‐ and α2‐adrenergic receptors amplifies dopamine‐mediated locomotor activity in both rats and mice (2003) (34)
Influence of the Mesocortical/Prefrontal Dopamine Neurons on Their Target Cells a (1988) (34)
Heterogeneity of spike frequency adaptation among medium spiny neurones from the rat striatum (2003) (34)
In vivo and in vitro activation of soluble tryptophan hydroxylase from rat brainstem (1976) (34)
Is Protein Kinase C Activity Required for the N‐Methyl‐d‐Aspartate‐evoked Rise in Cytosolic Ca2+ in Mouse Striatal Neurons? (1994) (34)
Involvement of the dopamine nigrostriatal system in the picrotoxin effect on striatal acetylcholine levels (1977) (34)
Modulation of GABA release by α-amino-3-hydroxy-5-methylisoxazole-4-propionate and N-methyl-d-aspartate receptors in matrix-enriched areas of the rat striatum (1992) (34)
End product inhibition of serotonin synthesis in the rat striatum. (1972) (33)
Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat (1994) (33)
Neuropeptide K, scyliorhinin I and II: new tools in the tachykinin receptor field. (1988) (33)
Pleiotropic effects of lysophosphatidic acid on striatal astrocytes (1999) (33)
In vivo modulations by GABA-related drugs of met-enkephalin release in basal ganglia of the cat brain (1982) (33)
Subcellular localization of H3-norepinephrine in the rat brain and the effect of drugs. (1966) (33)
Pretreatment of Mouse Striatal Neurons in Primary Culture with 17β‐Estradiol Enhances the Pertussis Toxin‐Catalyzed ADP‐Ribosylation of Gαo,i Protein Subunits (1990) (32)
Glycine stimulates the spontaneous release of newly synthesized 3H-dopamine in rat striatal slices. (1979) (32)
Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors. (2004) (32)
Synergistic Effects of Acetylcholine and Glutamate on the Release of Arachidonic Acid from Cultured Striatal Neurons (1995) (31)
Connexin mRNA expression in single dopaminergic neurons of substantia nigra pars compacta (2006) (31)
Synergistic Regulation of Cytosolic Ca2+ Concentration by Adenosine and α1‐Adrenergic Agonists in Mouse Striatal Astrocytes (1991) (31)
Self-stimulation and catecholamines. 3. Effect of imposed or self-stimulation in the area ventralis tegmenti on catecholamine utilization in the rat brain. (1973) (30)
Application ofl-glutamic acid and substance P to the substantia nigra modulates in vivo [3H]serotonin release in the basal ganglia of the cat (1982) (30)
The effects of quipazine on 5-HT metabolism in the rat brain (1976) (30)
[3H]HARMALINE AS A SPECIFIC LIGAND OF MAO A–II. MEASUREMENT OF THE TURNOVER RATES OF MAO A DURING ONTOGENESIS IN THE RAT BRAIN (1979) (30)
Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons. (1977) (30)
Influence of the amino acids of substance P in the recognition of its receptor: Affinities of synthesized SP analogues for the specific 125I-BHSP binding site on rat brain synaptosomes (1986) (30)
Nicotine-induced inhibition of neuronal phospholipase A2. (1997) (30)
Evoked release of acetylcholine in the rat striatum by stimulation of tachykinin NK-1 receptors. (1991) (30)
Cortical α1-adrenergic regulation of acute and sensitized morphine locomotor effects (2001) (30)
Enhancement of glutamate release in the rat striatum following electrical stimulation of the nigrothalamic pathway (1986) (30)
Biogenic amine-sensitive adenylate cyclases in primary culture of neuronal or glial cells from mesencephalon (1984) (29)
In vivo evidence for GABAergic control of serotonin release in the cat substantia nigra. (1981) (29)
Costimulation of N-methyl-d-aspartate and muscarinic neuronal receptors modulates gap junctional communication in striatal astrocytes (2002) (29)
In vivo estimation of tyrosine hydroxylation in the dopaminergic terminals of the rat neostriatum (1974) (29)
Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat (1978) (29)
Respective contributions of neuronal activity and presynaptic mechanisms in the control of the in vivo release of dopamine. (1990) (29)
Reduced Uptake of Tritiated Noradrenaline in Tissues of Immunosympathectomized Animals (1965) (29)
The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of gaba transmission in the thalamic nucleus ventralis medialis in the cat (1987) (29)
Dopamine function in the prefrontal cortex. (1998) (29)
Depolarization-evoked release of N-acetyl-L-aspartyl-L-glutamate from rat brain synaptosomes. (1988) (28)
Nonsurgical treatment of osteoarticular tuberculosis. A retrospective study in 143 adults. (1999) (28)
NK-1 receptors are the only class of tachykinin receptors found on mouse cortical astrocytes (1991) (28)
Identification of an opioid peptide secreted by rat embryonic mixed brain cells as a promoter of macrophage migration (2000) (28)
Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9. (1986) (28)
Glucose Regulates Glutamate‐Evoked Arachidonic Acid Release from Cultured Striatal Neurons (1995) (27)
Evidence for extramitochondrial pyruvate dehydrogenase involved in acetylcholine synthesis in nerve endings (1978) (27)
5-HT release from ependymal surface of the caudate nucleus in ‘ence´phale isole´‘ cats (1977) (27)
In vitro and in vivo inhibition of N-acetyl-L-aspartyl-L-glutamate catabolism by N-acylated L-glutamate analogs. (1992) (27)
Somatostatin receptors on cortical neurones and adenohypophysis: comparison between specific binding and adenylate cyclase inhibition. (1987) (27)
A 19-kDa Protein Belonging to a New Family Is Expressed in the Golgi Apparatus of Neural Cells (*) (1995) (27)
THE SUBCELLULAR LOCALIZATION OF Ach SYNTHESIS IN RAT STRIATAL SYNAPTOSOMES INVESTIGATED WITH THE USE OF TRITON X‐100 (1975) (27)
Functional heterogeneity of the matrix compartment in the cat caudate nucleus as demonstrated by the cholinergic presynaptic regulation of dopamine release (1992) (27)
Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors. (2000) (27)
Competitive inhibition of N-acetylated-alpha-linked acidic dipeptidase activity by N-acetyl-L-aspartyl-beta-linked L-glutamate. (1990) (26)
The effect of drugs on the choline and acetylcholine content of the rat striatum following two methods of sacrifice (1977) (26)
Stimulating effect of short term ether anaesthesia on central 5-HT synthesis and utilization in the mouse brain. (1973) (26)
Influence of dopaminergic and noradrenergic afferents on their target cells in the rat medial prefrontal cortex. (1992) (26)
Two simian virus 40 (SV40)-transformed cell lines from the mouse striatum and mesencephalon presenting astrocytic characters. II. Interactions with mesencephalic neurons. (1986) (26)
Direct and indirect presynaptic control of dopamine release by excitatory amino acids (2005) (26)
In vivo activation by benzotropine of dopamine release and synthesis in the caudate nucleus. (1973) (26)
Involvement of septide-sensitive tachykinin receptors in inositol phospholipid hydrolysis in the rat urinary bladder (1995) (25)
Role of the lateral habenula in modulating nigral and striatal in vivo [3H]serotonin release in the cat (1981) (25)
Cholecystokinin: Corelease with dopamine from nigrostriatal neurons in the cat (1989) (25)
Distinct Properties of Cholecystokinin‐8 and Mixed Dopamine‐Cholecystokinin‐8 Neurons Innervating the Nucleus Accumbens (1985) (25)
Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons. (1980) (25)
Effects of electrical stimulation of various midline thalamic nuclei on the bilateral release of dopamine from dendrites and nerve terminals of neurons in the nigro-striatal dopaminergic pathways (1984) (25)
Diencephalic and mesencephalic efferents of the medial prefrontal cortex in the rat: Electrophysiological evidence for the existence of branched axons (2004) (25)
[Peritoneal tuberculosis: 27 cases in the suburbs of northeastern Paris]. (2002) (24)
Identification of CSF‐1 as a brain macrophage migratory activity produced by astrocytes (1998) (24)
N-Methyl-d-aspartate-evoked release of [3H]acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA (1997) (24)
2-Chloroadenosine potentiates the alpha 1-adrenergic activation of phospholipase C through a mechanism involving arachidonic acid and glutamate in striatal astrocytes (1992) (24)
Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice. (2003) (23)
Blockade of the picrotoxin-induced in vivo release of dopamine in the cat caudate nucleus by diazepam. (1977) (23)
A 21-kDa Polypeptide Belonging to a New Family of Proteins Is Expressed in the Golgi Apparatus of Neural and Germ Cells* (1998) (23)
Leiomyomatosis metastasizing to the spine. A case report. (1983) (23)
An electrophysiological analysis of some afferent and efferent pathways of the rat prefrontal cortex. (1983) (22)
Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: Distribution, regulation and relationship to coupling (1992) (22)
Irreversible blockade of monoamine oxidases reveals the critical role of 5‐HT transmission in locomotor response induced by nicotine in mice (2006) (22)
Effects of thioproperazine and apomorphine on dopamine synthesis in the mesocortical dopaminergic systems (1975) (22)
Regional Differences in the Rate of Turnover of Norepinephrine in the Rat Brain (1966) (21)
Jaundice due to isoniazid. (1961) (21)
Local cerebral metabolic effects induced by nigral stimulation following ventromedial thalamic lesions. I: Basal ganglia and related motor structures (1984) (21)
In Vivo Biosynthesis of 35S‐Substance P from [35S]Methionine in the Rat Striatum and Its Transport to the Substantia Nigra (1982) (21)
Cyclic AMP Accumulation Induces a Rapid Desensitization of the Cyclic AMP‐Dependent Protein Kinase in Mouse Striatal Neurons (1991) (21)
NK-1 tachykinin receptor in rat and guinea pig brains: Pharmacological and autoradiographical evidence for a species difference (1993) (21)
μ opioid control of the N-methyl-d-aspartate-evoked release of [3h]-acetylcholine in the limbic territory of the rat striatum in vitro: diurnal variations and implication of a dopamine link (2004) (21)
Origin of the acetyl moiety of acetylcholine in rat striatal synaptosomes: a specific pyruvate dehydrogenase involved in ACh synthesis? (1978) (20)
Oxygen free radicals enhance the nitric oxide-induced covalent NAD(+)-linkage to neuronal glyceraldehyde-3-phosphate dehydrogenase. (1995) (20)
Effects of nigral application of muscimol on release of [3H]γ-aminobutyrate and on multi-unit activity in various cat thalamic nuclei (1983) (20)
Do Secretin and Vasoactive Intestinal Peptide Have Independent Receptors on Striatal Neurons and Glial Cells in Primary Cultures? (1986) (20)
In vivo release of [3H]GABA in cat caudate nucleus and substantia nigra. I. Bilateral changes induced by a unilateral nigral application of muscimol (1983) (20)
Heterogeneous topographical distribution of the striatonigral and striatopallidal neurons in the matrix compartment of the cat caudate nucleus (1995) (20)
Distribution of dopaminergic terminals in rat cerebral cortex: role of dopaminergic mesocortical system in ventral tegmental area syndrome. (1977) (19)
Involvement of Dopamine Neurons in the Regulation of β‐Adrenergic Receptor Sensitivity in Rat Prefrontal Cortex (1990) (19)
Influence of the ascending monoaminergic systems on the activity of the rat prefrontal cortex. (1990) (19)
Functional Coupling of the NK1 Tachykinin Receptor to Phospholipase D in Chinese Hamster Ovary Cells and Astrocytoma Cells (1998) (19)
Presynaptic regulation of dopaminergic transmission in the striatum (1988) (19)
GABA in the intralaminar thalamic nuclei modulates dopamine release from the two dopaminergic nigro-striatal pathways in the Cat (1983) (19)
Attempts to localize the GABA receptors involved in the GABA-induced release of newly-synthesized [3H]dopamine in rat striatal slices (1979) (19)
Influence of the replacement of amino acid by its D-enantiomer in the sequence of Substance P. 1. Binding and pharmacological data (1991) (19)
Dopamine receptors and cholinergic neurons in the rat neostriatum. (1975) (19)
Topographical distribution of substance P in the cat substantia nigra (1979) (19)
Control of the release of newly synthetized 3H-5-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices (2004) (19)
17‐β Oestradiol Pretreatment of Mouse Striatal Neurons in Culture Enhances the Responses of Adenylate Cyclase Sensitive to Biogenic Amines (1989) (18)
Long-term Receptor Regulation Induced by Denervation of Heterologous Afferent Fibers: Functional Significance (1987) (18)
Distinct modifications by neurokinin1 (SR140333) and neurokinin2 (SR48968) tachykinin receptor antagonists of the N-methyl-d-aspartate-evoked release of acetylcholine in striosomes and matrix of the rat striatum (1998) (18)
Differential localization of3H-[Pro9]SP binding sites in the guinea pig and rat brain (1994) (18)
Evidence for a dopaminergic innervation of the cat lateral habenula: its role in controlling serotonin transmission in the Basal ganglia (1984) (18)
Role of the thalamus in the bilateral regulation of dopaminergic and GABAergic neurons in the basal ganglia. (1984) (18)
Sensory stimuli differentially affect in vivo nigral and striatal [3H]serotonin release in the cat (1982) (18)
Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [pro9]substance P of the N-methyl- d-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum (1996) (17)
In vivo release of transmitters in the cat basal ganglia. (1981) (17)
Release of newly synthesized 3h-dopamine in the striatum: An adaptation of the push-pull cannula method to awake restrained and anesthetized rats (1986) (17)
Reduced glucose metabolism enhances the glutamate-evoked release of arachidonic acid from striatal neurons (1996) (17)
Endothelin Stimulates Phospholipase D in Striatal Astrocytes (1997) (17)
Accelerated resensitization of the D1 dopamine receptor-mediated response in cultured cortical and striatal neurons from the rat: respective role of alpha 1-adrenergic and N-methyl-D-aspartate receptors (1994) (17)
Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines. (1972) (17)
Dopamine-induced homologous and heterologous desensitizations of adenylate cyclase-coupled receptors on striatal neurons. (1990) (16)
Substance P(6–11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder (1997) (16)
Estimation of the rate of 5-HT synthesis in the mouse brain by varius methods (2004) (16)
The determination of picogram levels of 5‐HT in biological fluids (1976) (16)
Regulations of the activity of the nigrostriatal dopaminergic pathways by cortical, cerebellar, and sensory neuronal afferences. (1978) (16)
Control of 5-HT release in the caudate nucleus and the substantia nigra of the cat. (1981) (16)
Cyclothiazide Unmasks an AMPA‐Evoked Release of Arachidonic Acid from Cultured Striatal Neurones (1996) (16)
Storage and Release of Monoamines in the Central Nervous System (1970) (16)
Role of active transport of tryptophan in the control of 5-hydroxytryptamine biosynthesis. (1974) (16)
Heterologous Regulation of Receptors on Target Cells of Dopamine Neurons in the Prefrontal Cortex, Nucleus Accumbens, and Striatum (1988) (16)
Cortical alpha 1-adrenergic regulation of acute and sensitized morphine locomotor effects. (2001) (16)
Tachykinin Receptors: Binding and Cellular Activity Assays (1991) (16)
Discussion of stimulation-induced release of serotonin. (1968) (15)
Contribution of endogenously formed arachidonic acid in the presynaptic facilitatory effects of NMDA and carbachol on dopamine release in the mouse striatum (1999) (15)
Substance P‐Induced Reduction in the Initial Accumulation of Cytosolic myo‐[3H]Inositol in Rat Parotid Acinar Cells Mediated by the NK1 Tachykinin Receptor (1989) (15)
In Vivo Partial Inactivation of Dopamine D1 Receptors Induces Hypersensitivity of Cortical Dopamine‐Sensitive Adenylate Cyclase: Permissive Role of α1‐Adrenergic Receptors (1992) (15)
Estimation of chronic dopamine release from the caudate nucleus of the Macaca mulatta. (1974) (15)
Release of Monoamines in the Central Nervous System (1970) (15)
Regulation of 5-HT Synthesis in Central Serotoninergic Neurons (1973) (15)
Disposition and role of newly synthesized amines in central catecholaminergic neurons. (1972) (15)
Placebo-Controlled Study of the Analgesic Efficacy of a Paracetamol 500mg /Codeine 30mg Combination Together with Low-Dose vs High-Dose Diclofenac in Rheumatoid Arthritis (1999) (15)
2‐Deoxyglucose and NMDA inhibit protein synthesis in neurons and regulate phosphorylation of elongation factor‐2 by distinct mechanisms (2006) (15)
Electrical Synapses in Basal Ganglia (2007) (15)
Local and remote effects of intra-caudate administration of GABA-related drugs on met-enkephalin release in the basal ganglion (1985) (15)
NMDA regulation of dopamine release from proximal and distal dendrites in the cat substantia nigra (1994) (15)
Effects of ventro-medial mesencephalic tegmentum (VMT) stimulation on the spontaneous activity of nucleus accumbens neurones: Influence of the dopamine system (1986) (14)
Morphine and delta-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus. (1981) (14)
Biochemical and behavioural consequences of interactions between dopaminergic and noradrenergic systems in rat prefrontal cortex (1992) (14)
Albumin stimulates monocyte chemotactic protein‐1 expression in rat embryonic mixed brain cells (2005) (14)
Nicotine inhibits slowly inactivating K+ currents in rat cultured striatal neurons (1997) (14)
Isolated neuronal growth cones from developing rat forebrain possess adenylate cyclase activity which can be augmented by various receptor agonists. (1988) (14)
Synthesis and release of serotonin in the median eminence of the rat. (1970) (14)
In vivo release of [3H]GABA in cat caudate nucleus and substantia nigra. II. Involvement of different thalamic nuclei in the bilateral changes induced by a nigral application of muscimol (1984) (14)
IN VITRO Ca2+ DEPENDENT PROTEOLYSIS IN BRAIN TISSUES: A POSSIBLE SOURCE OF ERROR IN TRANSMITTER METABOLISM STUDIES (1974) (14)
Pharmacological characterization of tachykinin septide-sensitive binding sites in the rat submaxillary gland (1999) (14)
Sequential and opposite regulation of two outward K(+) currents by ET-1 in cultured striatal astrocytes. (2001) (13)
An isolated growth cone-enriched fraction from developing rat brain has substance P binding sites. (1988) (13)
AMPA receptor activation induces association of G‐beta protein with the alpha subunit of the sodium channel in neurons (2001) (13)
In vitro and in vivo disposition of 3H-methiothepin in brain tissues (1979) (13)
Choline stimulates the synthesis and accumulation of acetate in a cholinergic neuroblastoma clone. (1977) (13)
Control by GABA and tachykinins of the evoked release of acetylcholine in striatal compartments under different modalities of NMDA receptor stimulation (2000) (13)
Zinc‐induced inhibition of protein synthesis and reduction of connexin‐43 expression and intercellular communication in mouse cortical astrocytes (2002) (13)
Acetylcholine release in the cat caudate nucleus measured with the choline oxidase method. (1985) (12)
A pro- and an anti-inflammatory cytokine are synthetised in distinct brain macrophage cells during innate activation (2005) (12)
A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum. (1993) (12)
Cyclic-amp dependent protein kinase in mouse striatal neurones and astrocytes in primary culture: development, subcellular distribution and stimulation of endogenous phosphorylation (1989) (12)
Increased turnover of cerebral norepinephrine during rebound of paradoxical sleep in the rat. (1968) (12)
Regulation of Synthesis and Release Processes in Central Catecholaminergic Neurons (1975) (12)
Effects of the unilateral nigral application of baclofen on dopamine release in the two caudate nuclei of the cat. (1979) (12)
N-Methyl-D-aspartate receptor activation inhibits protein synthesis in cortical neurons independently of its ionic permeability properties (2002) (12)
Role of arachidonic acid and glutamate in the formation of inositol phosphates induced by noradrenalin in striatal astrocytes. (1993) (11)
Use of morphine in nonmalignant joint pain: the Limoges recommendations. The French Society for Rheumatology. (1999) (11)
The striatonigral substance P pathway and dopaminergic mechanisms. (1982) (11)
The presynaptic stimulating effect of acetylcholine on dopamine release is suppressed during activation of nigro-striatal dopaminergic neurons in the cat (1979) (11)
In vivo evidence for a dendritic release of dopamine in the cat substantia nigra. (1979) (11)
Influence of Afferent Systems on the Activity of the Rat Prefrontal Cortex: Electrophysiological and Pharmacological Characterization (1994) (11)
Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra. (1977) (11)
Presynaptic regulation of striatal dopamine release: in vivo and in vitro studies. (1982) (11)
Existence of dopaminergic nerve terminals in the rat cortex (1974) (11)
Local cerebral metabolic effects induced by nigral stimulation following ventromedial thalamic lesions. II: Sensory motor, reticular and limbic systems (1985) (10)
The Relative Roles of Neuronal Activity and Direct Presynaptic Mechanisms in Controlling the Release of Dopamine from the Cat Caudate Nucleus a (1986) (10)
Stimulatory effect of arachidonic acid on the release of GABA in matrix-enriched areas from the rat striatum (1996) (10)
Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker (1978) (10)
[Angiotensin II and nigostriatal system (author's transl)]. (1981) (10)
The new neurokinin 1‐sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA‐evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum (2003) (10)
Both Astrocytes and Neurons Contribute to the Potentiation Mediated by α1‐Adrenoceptors of the β‐Adrenergic‐Stimulated Cyclic AMP Production in Brain (1990) (10)
Chapter 18 Tachykinin receptors in the CNS (1987) (10)
In vivo spontaneous and evoked release of newly synthesized dopamine in the cat caudate nucleus. (1974) (10)
Role of arachidonic acid in the regulation of the NMDA‐evoked release of acetylcholine in striatal compartments (1999) (10)
A cyclic analogue selective for the NKB specific binding site on rat brain synaptosomes. (1986) (10)
Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems. (1975) (10)
Control of the activity of the two dopaminergic systems by cortical, cerebellar and sensory afferents in the cat. (1979) (10)
In vivo release of 3H-GABA synthesized from 3H-Glutamine in the substantia nigra and the pallido entopeduncular nuclei in the cat. (1981) (10)
Adenosine and somatostatin potentiate the alpha 1-adrenergic activation of phospholipase C in striatal astrocytes through a mechanism involving arachidonic acid and glutamate. (1993) (10)
Rat Mesocortical Dopaminergic Neurons Are Mixed Neurotensin/Dopamine Neurons: Immunohistochemical and Biochemical Evidence (1988) (9)
The novel 5-HT2 receptor antagonist, RP 62203, selectively blocks serotoninergic but not dopaminergic-induced inhibition in the rat prefrontal cortex. (1991) (9)
Striatal Dopamine Release In Vitro: A β‐Adrenoceptor‐Regulated Response Not Mediated Through Cyclic AMP (1982) (9)
Antiepileptic drugs to treat pain in rheumatic conditions. Recommendations based on evidence-based review of the literature and expert opinion. (2009) (9)
Adaptive reaction of nigral neurons following lesion of their ventromedial-thalamic projection field (1984) (9)
In vitro effects of 17 beta-oestradiol on the sensitivity of receptors coupled to adenylate cyclase on striatal neurons in primary culture. (1990) (9)
Distinct presynaptic control of dopamine release in striosomal-and matrix-enriched areas of the rat striatum by selective agonists of NK 1 , NK 2 , and NK 3 tachykinin receptors ( sftosme / autora phc lan ) (9)
The major role of the tryptophan active transport in the diurnal variations of 5-hydroxytryptamine synthesis in the rat brain. (1974) (9)
Different regulations of dopaminergic (D1) receptors and neurotensinergic binding sites in the rat prefrontal cortex (1991) (9)
D2-dopaminergic agonist quinpirole and 8-bromo-cAMP have opposite effects on Go alpha GTP-binding protein mRNA without changing D2 dopamine receptor mRNA levels in striatal neurones in primary culture. (1993) (9)
[Widening of a cervical intervertebral foramen by a vertebral megadolichoartery]. (1983) (9)
Long-term local and distal increases in tryptophan hydroxylase activity following intracerebral kainic acid injections in the rat (1982) (8)
Effects of peripheral and local administration of picrotoxin on the release of newly synthesized 3H-dopamine in the caudate nucleus of the cat (1977) (8)
Differential localization of 3H-[Pro9]SP binding sites in the guinea pig and rat brain. (1994) (8)
Properties of a 125I-substance P derivative binding to synaptosomes from various brain structures and the spinal cord of the rat (1983) (8)
Two simian virus 40 (SV40)-transformed cell lines from the mouse striatum and mesencephalon presenting astrocytic characters. III. A light and electron microscopic study. (1986) (8)
Effect of external ACh and of atropine on 14C-ACh synthesis and release in rat cortical slices (1977) (8)
COOPERATIVE CONTRIBUTION OF AMPA AND NMDA RECEPTORS IN THE LGLUTAMATE‐EVOKED RELEASE OF DOPAMINE FROM SYNAPTOSOMES OF THE RAT STRIATUM. (1992) (8)
Impact of 6‐hydroxydopamine lesions and cocaine exposure on µ‐opioid receptor expression and regulation of cholinergic transmission in the limbic–prefrontal territory of the rat dorsal striatum (2007) (8)
Tachykinin binding sites in the interpeduncular nucleus of the rat: normal distribution, postnatal development and the effects of lesions (1988) (8)
Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortical systems (2004) (8)
Inhibitory effects of mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization (1992) (7)
Recent finding on dopaminergic transmission in the basal ganglia. (1990) (7)
A combined light and electron microscopic method for the visualization of the same in vitro neuron by radioautography and serial sections (1984) (7)
Activation of ionotropic glutamate receptors reduces the production of transforming growth factor‐ß2 by developing neurons (2000) (7)
Does bicuculline antagonize NMDA receptors? Further evidence in the rat striatum (1994) (7)
Further evidence for the heterogeneous storage of noradrenaline in central noradrenergic terminals (2004) (7)
Glutamate induces the release of arachidonic acid by interacting with an atypical metabotropic receptor present on mouse brain astrocytes. (1994) (7)
DIFFERENTIAL INFLUENCE OF DOPAMINERGIC AND NORADRENERGIC AFFERENTS ON THEIR TARGET CELLS IN THE RAT PREFRONTAL CORTEX (1992) (7)
Inhibition of Astrocyte Gap Junctions by Endothelins (1995) (7)
BIOCHEMICAL AND MORPHOLOGICAL CHANGES AFTER MECHANICAL OR CHEMICAL DEGENERATION OF THE DOPAMINERGIC NIGRO-NEOSTRIATAL PATHWAY (1974) (7)
Characteristics of serotonin receptors in the rat brain. (1980) (7)
Evidence for a specific uptake of dopamine by dopaminergic terminals of the rat cerebral cortex (2004) (7)
IN VIVO RELEASE OF 3H-DA FROM THE CAT CAUDATE NUCLEUS (1973) (6)
GABA is toxic for mouse striatal neurones through a transporter‐mediated process (2002) (6)
(3H-Pro9) SP, a new selective ligand for NK-1 binding sites (1988) (6)
3H‐labelling of substance P by tritium exchange and deshalogenation (1980) (6)
Different effects of electrical stimulation of the mesencephalic and pontine reticular formation on the release of dopamine and acetylcholine in the cat caudate nucleus (1987) (6)
[Peripheral neuropathy with epineural vasculitis and transverse myelitis in systemic lupus erythematosus]. (1993) (6)
[Neuromeningeal tuberculosis in northeastern suburbs of Paris. Nineteen cases]. (2002) (6)
Effects of Tachykinins on Dopamine Release in the Striatum: In Vitro and In Vivo Studies (1987) (6)
Intercellular Diffusional Coupling between Glial Cells in Slices from the Striatum (2002) (6)
Cortico‐Subcortical Interactions in Behavioral Sensitization: Differential Effects of Daily Nicotine and Morphine (1992) (6)
In Vivo Measurement of [3H]GABA Release: An Approach to the Study of the Regulation of GABA‐Containing Neurons in the Basal Ganglia and Associated Structures in the Cat and the Rat a (1986) (5)
Pretreatment of mouse striatal neurons in primary culture with 17 beta-estradiol enhances the pertussis toxin-catalyzed ADP-ribosylation of G alpha o,i protein subunits. (1990) (5)
Pulmonary fat embolism treated by intermittent continuous positive airway pressure given by face mask. (1980) (5)
Synergistic effects in the alpha 1- and beta 1-adrenergic regulations of intracellular calcium levels in striatal astrocytes. (1991) (5)
Is cortical dopamine only the precursor of noradrenaline? (1973) (5)
Inhibitory effects of substance P and carbachol on the saturable sodium-dependent uptake process of myo-inositol in rat parotid gland. (1991) (5)
Role of excitatory amino acids in the direct and indirect presynaptic regulation of dopamine release from nerve terminals of nigrostriatal dopaminergic neurons (1991) (5)
Transport of dopamine in discrete areas of the striatum and of cerebral cortex in the rat. (1976) (5)
ROLE OF BRAIN CAT EC HOL AMINES IN THE CONTROL OF ANTERIOR PITUITARY FUNCTIONS (1970) (5)
Adaptive responsiveness of some central receptors to the denervation of heterologous afferent fibers: functional significance and possible behavioral consequences. (1987) (5)
Conformationally Restricted Analogues of Substance P (1987) (5)
GABA in the thalamic motor nuclei modulates dopamine release from the two dopaminergic nigrostriatal pathways in the cat (2004) (5)
Tachykinin receptors in the CNS. (1987) (4)
Synergistic regulation of cytosolic Ca2+ concentration by somatostatin and α 1-adrenergic agonists in mouse astrocytes (1992) (4)
Myoinositol Uptake in Rat Parotid Gland (1991) (4)
Nicotine: A new neuroprotective agent? (1994) (4)
Control of dopamine release by acetylcholine and dynorphin in the striosomal and matrix compartments of the cat caudate nucleus (1992) (4)
10 – Dopamine Release and Neuronal Activity in the Two Nigrostriatal Systems (1985) (4)
Involvement of cortico-striatal "glutamatergic" neurons in the presynaptic control of dopamine release in the cat caudate nucleus. (1986) (4)
EFFECTS OF GABA-ERGIC AND SEROTONINERGIC DRUGS ON THE ACTIVITY OF CHOLINERGIC INTERNEURONS IN RAT STRIATUM (1978) (4)
In vivo continuous estimation of 3H-dopamine synthesis and release in the cat caudate nucleus (1973) (4)
The use of l-3,5-[3H]-tyrosine and the measurement of tritiated water to estimate DA turnover in central dopaminergic terminals (1976) (4)
Selective agonists of tachykinins (1988) (4)
Cyclic AMP reduces adhesion of isolated neuronal growth cones from developing rat forebrain to an astrocytic cell line from embryonic mouse striatum (1989) (4)
In vivo release of newly synthesized catecholamines from the hypothalamus by amphetamine (2004) (4)
A peptidases-resistant glycosylated analogue of substance P-(5–11). Specificity towards substance P receptors (1984) (4)
Influence of Cortico-Striatal Glutamatergic Neurons on Dopaminergic Transmission in the Striatum (1991) (4)
[Primary pericardial sarcoma]. (2003) (4)
DENDRITIC RELEASE OF DOPAMINE: ITS ROLE IN THE CONTROL OF NIGROSTRIATAL DOPAMINERGIC NEURONES (1979) (4)
Treatment of intact striatal neurones with cholera toxin or 8-bromoadenosine 3',5'-(cyclic)phosphate decreases the ability of pertussis toxin to ADP-ribosylate the alpha-subunits of inhibitory and other guanine-nucleotide-binding regulatory proteins, Gi and Go. Evidence for two distinct mechanisms. (1991) (3)
Changes in striatal da metabolism induced by cholinergic and anti-cholinergic nigral stimulation in the rat (1974) (3)
[Demonstration of the liberation of dopamine (DA) and serotonin (5HT) at the caudate nucleus level in the rat]. (1969) (3)
[Urinary schistosomiasis and articular manifestations (apropos of 2 cases)]. (1973) (3)
The Effect of Acute and Repeated Nicotine Injections on Brain Dopamine Activation: Comparisons with Morphine and Amphetamine (1991) (3)
The Hypothalamus-Pituitary System: An Anatomical Overview (1990) (3)
Selective presence of a high density of NK-1 receptors on astrocytes from the rat brain stem in primary culture (1988) (3)
[Biosynthesis, storage and release of dopamine at the level of the dopaminergic nigro-neostriatal system]. (1973) (3)
Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat (2005) (3)
Synergistic effects in theα1- andβ1-adrenergic regulations of intracellular calcium levels in striatal astrocytes (1991) (3)
Role of various amino acids on the modulation of dopamine release from nigro-striatal dopaminergic neurones. (1979) (3)
[A new tachykinin receptor revealed by substance P analogues in the guinea pig ileum]. (1992) (3)
[Gardner-Diamond syndrome in a male. Trial treatment with beta-blockers]. (1981) (3)
Physiological presynaptic facilitation of dopamine release in the cat caudate nucleus. (1986) (3)
Inhibition of striatal dopamine synthesis in rats injected chronically with neuroleptics in their early life (2004) (3)
Reactivity of the Mesocortical Dopaminergic Neurones to Stress: Pharmacological Aspects (1979) (3)
Selectivity of neuropeptide K and of scyliorhinin I and II for NK-1, NK-2 or NK-3 receptors (1988) (3)
Ontogenesis of neostriatal cholinergic neurones in the rat and development of their sensitivity to neuroleptic drugs (2004) (3)
Role of thalamic motor nuclei in bilateral regulation of serotoninergic transmission in cat basal ganglia (1984) (3)
[Pro9]SP and septide interact with two types of tachykinin receptors in the guinea-pig ileum (1992) (2)
Presynaptic Regulation of Dopamine Release in Striatal Compartments and Functional Heterogeneity of the Matrix (1994) (2)
Intrastriatal regulation of DA release from dopaminergic terminals. (1979) (2)
NKB stimulates phospholipase C activity in the rat urinary bladder by acting on both NK2 and septide-sensitive receptors (1994) (2)
Somatostatin potentiates the a 1-adrenergic activation of phospholipase C in striatal astrocytes through a mechanism involving arachidonic acid and glutamate ( ae-adrenerglc receptor / somatostatin receptor / phospopase C / pospbolipase A 2 ) (2)
[Selective action of neuroleptics on the cholinergic neurons of the neostriatum in the rat: antagonism to apomorphine]. (1974) (2)
In vitro studies on central dopaminergic neurons' development. (1983) (2)
[Tolerance and dependence on opioid analgesics: experimental and clinical aspects]. (2000) (2)
[Functional properties of tachykinin receptors in the central nervous system]. (1993) (2)
In vivo release of newly synthesized GABA in the basal ganglia of the cat. (1981) (2)
Presynaptic Regulation of Dopamine Release from Synaptosomes of the Rat Striatum is Controlled by Different Types of Glutamate Receptors (1991) (2)
Regulation of catecholamine synthesis in the CNS (1973) (2)
[Effect of lesions of the ventromedial nucleus of the thalamus on cerebral metabolism: experimental study in the rat using the 14C-deoxyglucose method]. (1986) (2)
REGULATION OF DA SYNTHESIS IN THE NIGRO NEOSTRIATAL SYSTEM (1973) (2)
Regulations of Activity of the Nigrostriatal Dopaminergic Systems (1978) (2)
Role of Gabaergic and Glycinergic Transmissions in the Substantia Nigra in the Regulation of Dopamine Release in the Cat Caudate Nucleus (1978) (1)
Dopaminergic control of 125 I-labeled neurotensin binding site density in corticolimbic structures of the rat brain ( autoradiography / hetero-regulation / mesocorticolimbic dopaminergic neurons ) (1)
[Thrombosis of the superior longitudinal sinus after sacculoradiculography with iopamidol]. (1986) (1)
NEUROTRANSMITTER RELEASE IN VIVO AND ITS REGULATION (1981) (1)
Continuous determination of 3H-labelled 3,4-dihydroxyphenethylamine (dopamine) synthesis and release in the cat caudate nucleus in vivo. (1976) (1)
Peptidergic Regulation of Cholinergic Transmission in the Dorsal Striatum (2005) (1)
Effects of acetylcholine and atropine on the release of 14C-acetylcholine formed from U-14C-glucose in rat brain cortical and striatal prisms (1978) (1)
Mesocortical Dopamine‐Neurotensin Neurons (1992) (1)
New developments in the study of the mechanism of action of neuroleptics and amphetamine. (1974) (1)
[Paget, algodystrophy and total hip prosthesis]. (1982) (1)
Synergistic effects of acetylcholine and glutamate on the release of arachidonic acid from striatal neurons in culture (1994) (1)
Evidence for phosphatidylinositol anchorage of opioid binding proteins in rat brain (1990) (1)
Sulfhydryl reagents have different effects on substance P and neurokinin B binding sites on cortical synaptosomes in the rat (1987) (1)
Involvement of NMDA Receptors in the Presynaptic Regulation of Dopamine Release in Striosome-and Matrix-enriched Areas of the Rat Striatum (1991) (1)
In Vivo Regulation of Nigro-striatal and Mesocortico-prefrontal Dopaminergic Neurons (1982) (1)
Dopaminergic Antagonists Enhance Tyrosine Hydroxylase Activation in Depolarised Striatal Slices (1986) (1)
CHANGES OF 3H-DOPAMINE AND 3H-GABA RELEASE IN THE RAT BASAL GANGLIA INDUCED BY PHARMACOLOGICAL MODIF=ICATIONS OF DOPAMINERGIC TRNSMISSION (1984) (1)
Dendritic release of substances in the substantia nigra (1985) (1)
[Myeloma in a patient with Paget's disease of bone. A new case]. (1980) (1)
IN VIVO DEMONSTRATION OF PRESYNAPTIC FACILITATION OF DOPAMINE RELEASE BY STRIATAL AFFERENCES IN THE CAT (1984) (1)
[Beta blocking agents in the treatment of algo-neuro-dystrophies. Apropos of 34 cases]. (1977) (1)
[Histiocytosis X in adults. Apropos of a case with apparently isolated bone localizations and hypercalcemia, and a fatal course]. (1986) (1)
Presynaptic Regulation of Dopamine Release (2002) (1)
Further evidence for the existence of peripheral tachykinin septide-sensitive receptors (1994) (0)
[Chondrocalcinosis and hypothyroidism (2 cases)]. (1977) (0)
[Increasing of synthesis and utilization of serotonin (5HT) in central nervous system (SNC) of rats during deprivation of paradoxical sleep (SP)]. (1970) (0)
Electrical Synapses between Output Neurones of the Striatum and between Neurones of the Substantia Nigra Pars Compacta (2005) (0)
The Limoges guidelines for the use of morphine for noncancerous rheumatological pain (2008) (0)
[Congenital analgesia to pain and its osteoarticular manifestations]. (1971) (0)
Modulation of in vivo nigral 5HT release in the cat. (1983) (0)
[Relation between GABAergic and dopaminergic neurons in the basal ganglia]. (1987) (0)
Lack of involvement of dopaminergic and GABA neurones in the inhibitory effect of harmaline on the activity of striatal cholinergic neurones in the rat (1977) (0)
[Retroauricular tumefaction disclosing a histologically benign meningioma]. (1982) (0)
Effect of some neurotransmitters on the release of dopamine in rat striatal slices. (1979) (0)
[Augmentation of the synthesis of serotonin in rats selectively deprived of paradoxical sleep]. (1968) (0)
[Anesthetic properties of a new inhibitor of glutaminergic transmission in the central nervous system, riluzole]. (1989) (0)
LOCAL INJECTION OF PRAZOSIN IN THE VTA DOES NOT PREVENTTHE HYPERLOCOMOTOR EFFECT OF SYSTEMIC D‐AMPHETAMINE (1998) (0)
[Local metabolism of catecholamines in various nuclei of the brain in rats]. (1969) (0)
Recommendations Antiepileptic drugs to treat pain in rheumatic conditions. Recommendations based on evidence-based review of the literature and expert opinion * (2008) (0)
[Bone metastasis of a benign uterine leiomyoma. First case in the literature]. (1983) (0)
CHANGES IN STRIATAL DA METABOLISM INDUCED BY CHOLINERGIC AND ANTICHOLINERGIC NIGRAL STIMULATION IN THE RAT (1973) (0)
Evidence for a new type of tachykinin receptors in the guinea-pig ileum (1992) (0)
P(7–11), a Tritiated Septide-Like Peptide, in Chinese Hamster Ovary Cells Expressing Human Neurokinin-1 Receptors and in Rat Submandibular Glands (1997) (0)
[Acute monoarthritis after gastro-jejunal bypass for obesity]. (1983) (0)
Initial steps of the dopamine story (2017) (0)
Myoinositol uptake in rat parotid gland. A selective bioassay for NK1 receptors. (1991) (0)
NEW DEVELOPMENTS IN THE STUDY OF THE MECHANISM OF ACTION OF NEUROLEPTICS AND AMPHETAMINE (1975) (0)
[A case of Osler's disease with rheumatic signs, presence of streptococci in the muscle; late onset of dermatomyositis]. (1980) (0)
メテルゴリン,中枢5‐HT受容器しゃ断薬,による脳の5‐HTターンオーバの逆説的減少 (1978) (0)
New Insights About Chemical Transmission in the Brain (1988) (0)
The mapping of the central aminergic pathways (1999) (0)
Medical Assistants—a new Cinderella? (1966) (0)
In Vitro Studies on the Maturation of the Ascending Mesencephalic Dopaminergic Neurons (1984) (0)
[Arguments in favor of the extramitochondrial origin of the acetyl radical of acetylcholine synthetized in rat striatum synaptosomes]. (1978) (0)
Corrigendum to “basal ganglia and processing of cortical information: functional interactions between trans-striatal and trans-subthalamic circuits in the substantia nigra pars reticulata” [neuroscience 117 (4) 931–938] (2003) (0)
[Case of pheochromocytoma of the bladder]. (1973) (0)
[300 case-histories of lower back pain]. (1979) (0)
[The 1980 years]. (2015) (0)
[Increase of newly synthetized norepinephrine (NA) liberation under the effect of stress in the central nervous system (C.N.S.) in rats]. (1970) (0)
[A curious case of renal colic]. (1972) (0)
[Primary hyperparathyroidism and secondary polycythemia]. (1988) (0)
8-Bromo cyclic AMP differently regulates astrocytic Go,i proteins depending on the cell culture conditions (1990) (0)
Do inputs originating from functionally distinct cortical areas segregate or converge in the subthalamic nucleus (2000) (0)
558 – REACTIVITY OF THE MESOCORTICAL DOPAMINERGIC NEURONS TO STRESS: PHARMACOLOGICAL ASPECTS (1978) (0)
EFFECTS OF VARIOUS FORMS OF STRESS ON THE TURNOVER OF [3H]NOREPINEPHRINE IN THE RAT BRAIN (1969) (0)
[125I]-Bolton Hunter Substance P Specific Binding Sites on Cortical Astrocytes from New Born Mouse in Primary Culture (1987) (0)
Chronic Methods to Study the Release of Catecholamines from the Neostriatum in Nonanaesthetized Monkeys (Macaca mulatta) 1 (1979) (0)
[Daily fluctuations of serotonin (5-HT) biosynthesis and liberation in different cerebral structures in rats]. (1972) (0)
Reactivity of the Mesocortical Dopaminergic Neurones to Stress: Pharmacological Aspects (1979) (0)
[Liberation of newly synthesized dopamine (DA) at the level of the caudate nucleus in cats]. (1971) (0)
Tribute to Yves Laporte (2014) (0)
[Rheumatoid monoarthritis of the elbow]. (1972) (0)
Importance of the leucine side-chain in the differenciation of the receptors mediating the spasmogenic activities of NK-1 analogues and molecules from the “septide family” (1992) (0)
Jacques Glowinski (1936–2020) (2020) (0)
[Study of the regulation of the limitating stage of dopamine biosynthesis at the level of the rat striatum]. (1970) (0)
Information provided by nigrostriatal dopaminergic neurons, respective role of nerve activity and presynaptic influences in dopaminergic transmission (1985) (0)
Functional Significance of Long-term Receptor Hetero-regulation: Further Evidence for Dopaminergic Cortico-subcortical Relationships (1988) (0)
Risedronate is effective in preventing first vertebral fracture in women (2001) (0)
Both Astrocytes and Neurons Contribute to the Potentiation Mediated by alpha1-Adrenoceptors of the beta-Adrenergic-Stimulated Cyclic AMP Production in Brain. (1990) (0)
A671 EFFECT OF TRANSCUTANEOUS CRANIAL ELECTRICAL STIMULATION ON HALOTHANE REQUIREMENTS IN RATS (1990) (0)
DISTINCT REGULATION OF NMDA‐EVOKED DA RELEASE BY D1 and D2 ANTAGO‐NISTS IN THE STRIOSOME AND MATRIX COMPARTMENTS OF THE RAT STRIATUM. (1992) (0)
Remembrance: Celebrating the Man Behind the Science (2006) (0)
[Lack of participation of cytoplasmic choline in the synthesis of acetylcholine in the striatal synaptosomes of the rat]. (1978) (0)
Role of Various Nigral Afferences on the Activity of the Nigrostriatal Dopaminergic Pathways (1979) (0)
Neuropharmacologie (1983-2006) (2019) (0)
MODULATION OF GABA RELEASE THROUGH NMDA AND NON‐NMDA GLUTAMATERGIC RECEPTORS IN STRIOSOMES‐ AND MATRIX‐ENRICHED AREAS OF THE RAT STRIATUM. (1992) (0)
[Reciprocal interactions between the noradrenergic and dopaminergic systems in the prefrontal cortex and ventral tegmental area]. (1989) (0)
[Isolated paralysis of the external popliteal sciatic nerve. Moneneuritis form of Déjerine-Sottas disease]. (1978) (0)
VIP and secretin receptors linked to an adenylate cyclase on central neuronal and glial cells in primary cultures (1985) (0)
[Involvement of glutamate released from cortico-striatal fibers in the presynaptic control of dopamine liberation in the caudal nucleus of the cat]. (1989) (0)
Dopaminergic Hetero-regulation of Striatal μ-Opiate Receptors: Further Evidence for Their Postsynaptic Location (1991) (0)
[Recent acquisitions on cerebral metabolism of catecholamines]. (1967) (0)
[A case of osteomalacia due to lactose intolerance with bilateral osteonecrosis of the femoral heads]. (1973) (0)
初代培養線条体ニューロンにおいてD2‐ドーパミン作動性アゴニスト,キンピロールと8‐ブロモ‐cAMPはD2ドーパミン受容体mRNAレベルの変化なしにG0αGTP結合蛋白質mRNAに対し相反する効果を持つ (1993) (0)
Mixed irreversible MAOIs trigger locomotor response to nicotine in mice : Effects in mice knockout for the 2, 4,6 or 7 nAchR subunit. (2006) (0)
Local stimulatory effects of opiates on the in vivo release of dopamine in the cat caudate nucleus (1981) (0)
INFLUENCE OF THE MESOCORTICAL DA SYSTEM ON THE ACTIVITY OF PREFRONTAL CORTICAL NEURONS IN THE RAT (1984) (0)
[Reduction induced by substance P of the initial accumulation of myo(3H)inositol in acinar cells of the parotid gland in rats]. (1989) (0)
[Bilateral necrosis of the humeral head with omarthrosis in myocardial infarct]. (1972) (0)
[Algoneurodystrophy: treatment by betablockaders]. (1979) (0)
Regulations of Serotonergic Neurons Innervating the Basal Ganglia: In vivo Release Studies (1984) (0)
[L4 and L5 double nerve root pain following percutaneous nucleotomy at the L4-L5 level]. (1994) (0)
Involvement of K-opioid receptors in the direct and indirect presynaptic control of dopamine release by ACH in striosomal and matrix compartments of the cat caudate nucleus (1990) (0)
1316 – ROLE OF VARIOUS NIGRAL AFFERENCES ON THE ACTIVITY OF THE NIGROSTRIATAL DOPAMINERGIC PATHWAYS (1978) (0)
enhances the ATP-evoked release of acid from mouse astrocytes. (1997) (0)
Reopening Ceremony of the Renovated Buildings of Chemistry and Biology, and of the General Library of the Collège de France - 26 May 2009 (2009) (0)
How Much Food from the Sea? (2005) (0)
A new sensitive bioassay for tachkinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum (1994) (0)
Continuous Determination of 3 H-Labelled 3 , 4 Dihydroxyphenethylamine ( Dopamine ) Synthesis and Release in the Cat Caudate Nucleus in viva (2009) (0)

This paper list is powered by the following services:

Jacques Glowinski's Academic­Influence.com Rankings

Why Is Jacques Glowinski Influential?

Jacques Glowinski's Published Works

Published Works

Jacques Glowinski's AcademicInfluence.com Rankings